Norman D. Schwartz - 25 Aug 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Issuer symbol
BIO
Transactions as of
25 Aug 2023
Net transactions value
-$7,017,885
Form type
4
Filing time
28 Aug 2023, 13:29:48 UTC
Previous filing
01 Dec 2022
Next filing
06 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,081 +0.49% $0.000000 429,925 25 Aug 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $393,997 -1,032 -0.24% $381.78 428,893 25 Aug 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +1,266 +0.3% $0.000000 430,159 25 Aug 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $239,758 -628 -0.15% $381.78 429,531 25 Aug 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +1,805 +0.42% $0.000000 431,336 25 Aug 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $341,693 -895 -0.21% $381.78 430,441 25 Aug 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,320 +0.54% $0.000000 432,761 25 Aug 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $439,429 -1,151 -0.27% $381.78 431,610 25 Aug 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,600 +0.6% $0.000000 434,210 25 Aug 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $492,496 -1,290 -0.3% $381.78 432,920 25 Aug 2023 Direct
transaction BIO Bio-Rad B Common Stock Options Exercise $4,582,500 +39,000 +12% $117.50 370,689 25 Aug 2023 Direct
transaction BIO Bio-Rad B Common Stock Tax liability $9,693,012 -25,389 -6.8% $381.78 345,300 25 Aug 2023 Direct
holding BIO Bio-Rad B Common Stock 12,900 25 Aug 2023 By Spouse F2
holding BIO Bio-Rad B Common Stock 4,060,054 25 Aug 2023 By Blue Raven Partners, L.P. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -2,081 -25% $0.000000 6,245 25 Aug 2023 Bio-Rad A Common Stock 2,081 $0.000000 Direct F4, F5
transaction BIO Restricted Stock Units Options Exercise $0 -1,266 -33% $0.000000 2,532 25 Aug 2023 Bio-Rad A Common Stock 1,266 $0.000000 Direct F4, F6
transaction BIO Restricted Stock Units Options Exercise $0 -1,805 -50% $0.000000 1,805 25 Aug 2023 Bio-Rad A Common Stock 1,805 $0.000000 Direct F4, F7
transaction BIO Restricted Stock Units Options Exercise $0 -2,320 -50% $0.000000 2,320 25 Aug 2023 Bio-Rad A Common Stock 2,320 $0.000000 Direct F4, F8
transaction BIO Restricted Stock Units Options Exercise $0 -2,600 -100% $0.000000* 0 25 Aug 2023 Bio-Rad A Common Stock 2,600 $0.000000 Direct F4, F9
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -39,000 -100% $0.000000* 0 25 Aug 2023 Bio-Rad B Common Stock 39,000 $117.50 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F6 On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F7 On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F8 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F9 On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023.
F10 The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted.